Drug Safety Update: Risks of severe bradycardia and heart block when taken with amiodarone

Monday, 01 June 2015 03:49 Written by
Rate this item
(3 votes)

On the 20th May 2015 the Medicines and Healthcare products Regulatory Agency in the UK issued a Drug Safety Update titled:

Sofosbuvir with daclatasvir; sofosbuvir and ledipasvir: risks of severe bradycardia and heart block when taken with amiodarone.

You will find a link to it at:

https://www.gov.uk/drug-safety-update/sofosbuvir-with-daclatasvir-sofosbuvir-and-ledipasvir-risks-of-severe-bradycardia-and-heart-block-when-taken-with-amiodarone

Read 104489 times Last modified on Tuesday, 20 June 2017 02:43

Copyright © 2015-2017 FixHepC

Back to Top